Table 1.
Clinical characteristics at baseline
| Variable | Means ± s.d. | Min | Max |
|---|---|---|---|
| N (male/female) | 72 (8/64) | N/A | N/A |
| Weight (kg) | 81.91 ± 10.24 | 61.20 | 114.60 |
| BMI (kg/m2) | 30.25 ± 2.75 | 25.06 | 35.36 |
| SBP (mmHg) | 118.21 ± 10.07 | 100.00 | 147.00 |
| DBP (mmHg) | 77.80 ± 6.67 | 62.00 | 90.00 |
| HR (bpm) | 69.29 ± 6.79 | 48.00 | 90.00 |
| VAT mass (kg) | 3.15 ± 1.37 | 0.96 | 8.07 |
| Fat cell size (μl) | 0.77 ± 0.21 | 0.27 | 1.39 |
| Body fat (%) | 37.40 ± 5.58 | 18.62 | 45.25 |
| GLU (mg per 100 ml) | 96.35 ± 8.13 | 80.00 | 125.00 |
| CHO (mg per 100 ml) | 204.38 ± 32.38 | 137.00 | 288.00 |
| TG (mg per 100 ml) | 118.35 ± 70.81 | 19.00 | 338.00 |
| HDL (mg per 100 ml) | 56.61 ± 15.16 | 30.50 | 114.30 |
| LDL (mg per 100 ml) | 124.03 ± 31.99 | 42.80 | 208.60 |
| Delta EEa | 8.12 ± 8.46 | −10.21 | 26.92 |
| Adj EE (kcal per 24 h) | 2.37 ± 157.61 | −384.10 | 357.73 |
| RQ (au) | 0.86 ± 0.05 | 0.77 | 0.98 |
Abbreviations: Adj EE, lean body mass adjusted energy expenditure presented as the residuals from predicted; BMI, body mass index; CHO, cholesterol; DBP, diastolic blood pressure; Delta EE, energy expenditure change; GLU, glucose; HDL, high-density lipoprotein cholesterol; HR, heart rate; LDL, low-density lipoprotein cholesterol; RQ, respiratory quotient; SBP, systolic blood pressure; TG, triglycerides; VAT, visceral adipose tissue. N = 72 for the whole population.
a
Only subjects treated with ephedra and caffeine (E+C).